flow trial semaglutide kidney outcomes 2024 results Semaglutides Are Poised to Remake Chronic Disease Care FLOWing with the SemagluTIDE — – Patients with type 2 #diabetes

This work was supported by grants from the State Key Laboratory of Military Stomatology (2018ZB01)

Semaglutide, a medication widely used for managing type 2 diabetes and weight loss, has shown promising results in controlling blood sugar levels and promoting weight reduction

Patients who qualify for GLP-1 medications like Semaglutide or Tirzepatide often lose 1520% of their body weight over several months

Should you miss a dose, skip it, and resume your regular schedule the following day

Clinical trials show that people on semaglutide typically eat 35% less foodimagine naturally feeling satisfied after eating just under half of your usual dinner portion